ARCH Venture Partners — portfolio autopsies
ARCH Venture Partners has 3 portfolio companies documented in the UnicornBurn autopsy dataset with verified collapse causes and timelines. Most frequent failure cause: "unit-economics".
// dominant patterns
// 3 documented companies
// faq
- Which startups in ARCH Venture Partners's portfolio are documented in UnicornBurn?
- ARCH Venture Partners has 3 portfolio companies documented in UnicornBurn, including Achaogen, BIND Therapeutics, bluebird bio.
- What is the most common failure cause in ARCH Venture Partners's documented portfolio?
- The most frequent failure cause is "unit-economics", recorded in 2 of 3 documented cases.
- What collapse pattern dominates ARCH Venture Partners's documented failures?
- The predominant collapse pattern is "Bankruptcy". UnicornBurn documents 9 distinct collapse styles based on sequence and speed of failure.
// for funds & analysts
Access the full failure dataset with verified causes, timelines and pattern matching.
See Intelligence plans →// all investors
Explore the full investor directory with documented portfolio failures.
View all investors →Are you from this fund?